FDA recommends ban on blood collections from Zika-affected areas
WASHINGTON (Reuters) - The U.S. Food and Drug Administration (FDA) has recommended that blood no longer be collected from regions where the Zika virus is circulating, and that blood needed for transfusions be obtained from areas of the United States without active transmission.
Aucun commentaire:
Enregistrer un commentaire